Service de Biochimie et de
Génétique Moléculaire, CEA/Saclay, F-91191
Gif-sur-Yvette Cedex, France
Received 29 June 1999/Returned for modification 5 August
1999/Accepted 7 September 1999
TFIIIC plays a key role in nucleating the assembly of the
initiation factor TFIIIB on class III genes. We have characterized an
essential gene, TFC8, encoding the 60-kDa polypeptide,
60, present in affinity-purified TFIIIC. Hemagglutinin-tagged
variants of
60 were found to be part of TFIIIC-tDNA complexes and to
reside at least in part in the downstream DNA-binding domain
B.
Unexpectedly, the thermosensitive phenotype of N-terminally tagged
60 was suppressed by overexpression of
95, which belongs to the
A domain, and by two TFIIIB components, TATA-binding protein (TBP)
and B"/TFIIIB90 (but not by TFIIIB70). Mutant TFIIIC was deficient in
the activation of certain tRNA genes in vitro, and the transcription
defect was selectively alleviated by increasing TBP concentration.
Coimmunoprecipitation experiments support a direct interaction between
TBP and
60. It is suggested that
60 links
A and
B domains
and participates in TFIIIB assembly via its interaction with TBP.
 |
INTRODUCTION |
The primary step in tRNA gene
activation is the binding of TFIIIC to the A and B blocks of the
intragenic promoter. Its main function is then to assemble the
initiation factor TFIIIB upstream of the transcription start site
(30). Yeast TFIIIC (
factor) is a multisubunit protein of
ca. 600 kDa organized in two large globular domains
A and
B of
similar size and mass (10-nm diameter and ca. 300 kDa), each
interacting with one promoter element, as visualized by electron
microscopy (17, 53). Binding of
B to the B block is
predominant and favors the binding of
A to the A block
(4). TFIIIC-DNA interaction displays a remarkable adaptability to the variable A-B distances found in different tRNA
genes (3). Affinity-purified Saccharomyces
cerevisiae TFIIIC comprises six polypeptides of 138, 131, 95, 91, 60, and 55 kDa (6, 19, 47, 59). Gene cloning, protein-DNA
cross-linking, mutagenesis, and protein-protein interaction studies
provided a global view of the location and role of several TFIIIC
subunits within the TFIIIC-DNA complex.
138 and
91 subunits
reside in the
B domain and cooperate in downstream DNA binding
(1, 10, 36, 37);
95 and
55 interact physically, belong
to the
A domain, and are thought to participate in A block binding
(7, 17, 40, 48, 59).
131 (42) stands as the
TFIIIC subunit responsible for TFIIIB assembly based on genetic
evidence (49, 61), its upstream location (7), and
its interaction with two TFIIIB components (14, 33, 51).
TFIIIB is not a stable molecular entity like TFIIIC. It can be resolved
chromatographically into two fractions named B' and B" (29).
B' comprises TATA-binding protein (TBP) and the TFIIB-related factor
TFIIIB70/Brf1 (12, 16, 31, 39), while B" contains TFIIIB90
(32, 50, 51). The TFIIIC-dependent TFIIIB assembly on
TATA-less class III genes is a multistep pathway that could be
decomposed in vitro (29, 31) and reconstituted with
recombinant TFIIIB components (32, 51). The order of
interaction is TFIIIB70, then TBP, and then B", as shown by gel
retardation and DNA photo-cross-linking (31). TBP stabilizes
the weak interaction between TFIIIB70 and the TFIIIC-DNA complex but
the complete upstream footprint and the characteristic stability of the
TFIIIB-DNA complex requires the recruitment of B"/TFIIIB90 (29,
31). A cascade of conformational rearrangements at the protein
and DNA levels are accompanying these assembly steps, as evidenced by
successive changes in the accessibility of TFIIIB70, TBP, and
131 to
site-specific DNA cross-linking (31), by the DNA bending
induced upon TFIIIB binding (11, 38, 46), and by the
presence of a cryptic DNA binding domain in TFIIIB70 (24).
131 appears to play the major role in positioning TFIIIB since it is
the only TFIIIC subunit accessible to DNA cross-linking upstream of the
start site (5, 7) and found to interact with TFIIIB70
(14, 33) and TFIIIB90 (51). TFIIIB can effect its
own assembly onto the TATA-containing SNR6 gene through the
interaction of TBP with the strong TATA box (27, 43, 45).
Interestingly, Whitehall et al. (60) found that TBP could
not discern the polarity of the TATA element and directed TFIIIB
assembly in two orientations. However, in contrast to the TATA-dependent assembly, TFIIIC placed TFIIIB in the correct
orientation. Since no TFIIIC component was known to interact with TBP,
it was presumed that the unidirectional binding of TBP to the TATA box is dictated by the oriented interaction of TFIIIB70 with
131 (60).
In the present work we have completed the characterization of TFIIIC
components by cloning a yeast gene, named TFC8, that encodes
the 60-kDa polypeptide. We present genetic and biochemical evidence
that this component, named
60, resides at least in part within the
B domain and participates in TFIIIB recruitment via TBP binding.
 |
MATERIALS AND METHODS |
Yeast strains, plasmids, and genetic techniques.
YNN281×YNN282 (21) was used for gene disruption. Cells were
grown in standard rich medium (YPD) or minimal medium (Casamino acid
medium). The plasmids used for suppression studies are described in
Lefebvre et al. (37). Preparation of media, tetrad
dissection, transformation of lithium acetate-treated cells, and
plasmid shuffling by using 5-fluoro-orotic acid were performed by
standard techniques (2).
Amino acid sequence determination.
The polypeptide
components of purified TFIIIC preparation were separated by preparative
electrophoresis on a 6% polyacrylamide-sodium dodecyl sulfate (SDS)
gel (36). The gel was lightly stained with Coomassie blue. A
gel slice containing the 60-kDa polypeptide was excised, crushed, and
subjected to trypsin digestion. Preparation and analysis of tryptic
peptides have been previously described (36, 59). One
peptide sequence was partially determined (??TLYLTT[T/F]PT).
Cloning, construction of plasmids, and disruption of
TFC8.
Two 32-mer oligonucleotides were used to amplify the
open reading (ORF) frame of TFC8 by PCR on yeast genomic
DNA. The resulting DNA fragment was then labeled with
[
-32P]dCTP and used to screen the FL100 library
(57) containing yeast genomic DNA fragments inserted into
the pFL44L (2µ, URA3) plasmid (9). The pFL44L
plasmid isolated from one of the hybridizing clones was found to
contain a large DNA insert comprising the TFC8 gene and was
named pCC12 (pFL44L-TFC8). The 2.3-kb
SalI-FspI DNA fragment from pCC12 harboring the
TFC8 gene was cloned into pUN45 creating the pYED1 plasmid.
A 69-mer oligonucleotide was used to introduce a NdeI
restriction site at the initiation codon of TFC8, followed
by the sequence encoding the hemagglutinin (HA) epitope (YPYDVPDYA)
derived from the influenza virus HA protein (62), by
oligonucleotide-mediated mutagenesis on single-stranded pYED1 DNA by
using a Muta-Gene kit (Bio-Rad), yielding the pYED2 plasmid (encoding
HA Nter-
60). The sequence encoding the HA epitope was also
introduced before the stop codon of TFC8 by PCR-mediated mutagenesis with two oligonucleotides. One contained a SalI
restriction site and nucleotides complementary to the upstream region
of the TFC8 promoter, and the other harbored the sequence
encoding the HA epitope, a NotI restriction site, and
nucleotides complementary to the stop codon region of TFC8.
After PCR amplification, the SalI-NotI DNA
fragment was inserted into the corresponding sites of pYED1 to give
pYED3 (encoding for HA Cter-
60). The
NdeI-BamHI DNA fragment from pYED2 was inserted
into the corresponding sites of pET28c vector (Novagen), yielding pET60.
Disruption of the TFC8 gene was performed as previously
described (8, 40). Two 55-mer oligonucleotides harboring
sequences complementary to TFC8 and to the yeast
HIS3 selectable marker were used to amplify by PCR an
~1.1-kb DNA fragment containing the HIS3 gene flanked by
TFC8 promoter and terminator sequences. The PCR-amplified
DNA fragment was used to transform the strain YNN281×YNN282. The
structure of several His+ diploids was verified by PCR
analysis. To determine whether TFC8 was essential for
growth, sporulation and dissection analysis were performed. The diploid
His+ strain was also transformed with the pCC12 plasmid
(pFL44L-TFC8) and sporulated. A His+ spore
containing the pCC12 plasmid was chosen to give strain YCC8 used for
plasmid shuffling.
Purification of TFIIIC.
TFIIIC was purified starting from
~12 g of S. cerevisiae cells, using fast-protein liquid
chromatography-grade resins. The preparation of the cell extract was
done as described by Huet et al. (25). Crude extract was
first diluted to 0.25 M ammonium sulfate (AS) with buffer I (20 mM
Tris-HCl, pH 8.0; 0.5 mM EDTA; 10 mM
-mercaptoethanol; 10%
[vol/vol] glycerol) and then loaded at 2.5 ml/min on a 25-ml heparin
Hyper D (BioSepra) column previously equilibrated with buffer I (0.25 M
AS). The resin was then washed at 5 ml/min with 250 ml of buffer I
(0.35 M AS). A linear gradient of AS from 0.35 to 0.70 M in 180 ml of
buffer I was then applied at 2.5 ml/min. Fractions (2 ml) were
collected and assayed for TFIIIC-DNA binding activity.
TFIIIC-containing fractions (0.45 to 0.55 M AS) were pooled and
dialyzed against buffer I (0.07 M AS). Proteins were then loaded at 0.5 ml/min on a 1-ml MonoQ column (Pharmacia, Piscataway, N.J.) previously
equilibrated with buffer I (0.07 M AS). The column was washed at 0.5 ml/min with 20 ml of buffer I (0.07 M AS). A linear gradient of AS from
0.07 to 0.4 M in 15 ml of buffer I was then applied at 0.5 ml/min. Fractions (200 µl) containing TFIIIC-DNA binding activity were eluted
between 0.24 and 0.30 M AS. Based on Western blot experiments with
anti-
55 or anti-
60 antibodies, the TFIIIC preparation from Ntag-
60 mutant cells was found to contain half as much factor as the
wild type.
Expression and purification of
60 in Escherichia
coli.
Recombinant Tfc8p tagged at its N-terminal end with six
histidines and with the HA epitope (HA-r
60) was expressed from
plasmid pET60 in E. coli BL21 (pLysS). Cell culture, protein
induction, and extract preparation were performed as described earlier
(1). Crude cell extract was loaded at 1 ml/min on a 5 ml of
Ni2+-charged HiTrap chelating column (Pharmacia) previously
equilibrated with 20 mM HEPES (pH 7.8), 300 mM NaCl, and 10% glycerol
containing 10 mM imidazole. Proteins were eluted by a linear gradient
in 60 ml of the same buffer containing 20 to 270 mM imidazole at 1 ml/min. Fractions (1 ml) were assayed for HA-r
60 by Western blotting
with anti-
60 antibodies. Fractions containing HA-r
60 were eluted
at concentrations between 160 and 190 mM imidazole.
Anti-
60 polyclonal antibodies.
A 14-mer peptide (N-12-M)
encompassing the C-terminal amino acid residues of
60 was
synthesized (Neosystem, Strasbourg, France) and conjugated to
maleimide-activated keyhole limpet hemocyanin (KLH). N-12-M-KLH
conjugate was then injected into rabbits for antibody production in
three injections at about three week intervals.
Immunoprecipitation experiments.
rTBP alone (200 ng) or both
rTBP (200 ng) and HA-r
60 (650 ng) were preincubated for 90 min at
25°C in 40 µl of buffer A containing 20 mM HEPES (pH 8.0), 5 mM
MgCl2, 1 mM dithiothreitol (DTT), 0.1 mM EDTA, 5%
glycerol, 0.05% NP-40, and 110 mM KCl. Magnetic beads (Dynabeads/Dynal) coated with 12CA5 antibody were added to the mixtures. The beads were incubated with gentle shaking for 3 h at
10°C and then washed three times in buffer A. Bound proteins were
eluted by boiling in Laemmli sample buffer, separated by SDS-polyacrylamide gel electrophoresis (PAGE) and analyzed by Western
blotting by using a mixture of polyclonal antibodies directed to TBP
and to
60. Bound antibodies were revealed by using the Amersham ECL
Kit. The polypeptides revealed by antibodies directed to TBP or
60
were identified in independent experiments.
DNA binding and in vitro transcription assays.
TFIIIC-tDNA
or
B-tDNA interaction was monitored by gel retardation analysis as
described previously (25, 37). A 32P-labeled DNA
fragment (3 to 10 fmol; 4,000 to 10,000 cpm) carrying the
tRNA3Glu (198 bp) or the
SUP4tRNATyr (375 bp) genes was incubated for 10 min at 25°C in a 15-µl reaction mixture containing 10 mM Tris-HCl
(pH 8.0), 10% glycerol, bovine serum albumin, DNA competitor, and
TFIIIC (MonoQ fraction). The final ammonium sulfate concentration was
75 mM.
B-tDNA complexes were obtained after a further 10 min
incubation at 25°C of TFIIIC-tDNA complexes with 10 ng of
-chymotrypsin (Sigma). Digestion was stopped by addition of 1 ng of
aprotinin (Sigma). Complexes were analyzed by nondenaturing gel
electrophoresis (5% polyacrylamide).
Transcription mixtures (40 µl) contained 20 mM HEPES (pH 8.0); 5 mM
MgCl2; 1 mM DTT; 0.1 mM EDTA; 5% glycerol; 8 U of RNasin (Amersham); 0.6 mM each ATP, GTP, and CTP; 0.03 mM UTP and 10 µCi of
[32P]UTP; TFIIIB (370 ng of Cibacron-blue fraction) or
rTBP (250 ng); rTFIIIB70 (1.2 µg) and partially purified B" fraction
(1.8 µg); RNA polymerase III (Pol III; 50 ng); and TFIIIC (MonoQ
fraction) as indicated. The final KCl concentration was 110 mM. After
10 min of preincubation at 25°C, transcription reaction was initiated by addition of 130 ng of plasmid DNA harboring different tRNA genes and
allowed to proceed for 45 min at 25°C. Transcripts were analyzed by
electrophoresis on an 8 M urea gel (6% polyacrylamide).
In vivo labeling of RNAs and Northern blot analysis.
RNA
labeling was done with [3H]uracil with strains where the
ura3 mutation was complemented by the URA3
plasmid pFL44L. Cells were exponentially grown in uracil-free Casamino
acid medium supplemented with adenine (Casa+Ade) to an optical density
of 0.4 at 600 nm. Then, 150 µCi of [3H]uracil was added
to 10 ml of culture for 15 min. The cells were next harvested and
chilled with 10 ml of ice-cold sterile water. RNAs were extracted as
previously described (22, 52). Small RNA species were
analyzed by loading and separating equal amounts of RNA (6 µg per
lane) on a 7 M urea gel by electrophoresis (6% polyacrylamide).
RNA extraction and gel electrophoresis for Northern blot analysis were
performed as described in the previous section. Electrophoretic transfer on nylon membrane (Bio-Rad apparatus), UV cross-linking DNA
(Stratalinker apparatus), and hybridization with DNA probe in sodium
phosphate buffer were carried out as previously described (15). The DNA probe used in the Northern blot experiment
shown in Fig. 2B was a 327-bp 32P-labeled PCR fragment
encompassing the yeast tRNA3Leu gene amplified
from the pGE2 plasmid.
 |
RESULTS |
TFC8 encodes
60, the 60-kDa subunit of yeast
TFIIIC.
TFIIIC from S. cerevisiae comprises six
polypeptides of 138, 131, 95, 91, 60, and 55 kDa. In order to clone the
gene encoding the hypothetical
60 subunit, the polypeptide was
purified by SDS-PAGE and subjected to tryptic digestion. The sequence
of only one peptide could be determined (??TLYLTT[T/F]PT). When
compared to DNA sequences in databases by using the BLAST program, this peptide sequence was found with a slight variation (DGTLYLTTFPD) in a
unique yeast hypothetical protein of 588 residues, with a theoretical
molecular weight of 67,640 and an isoelectric point of 5.87. The gene
encoding this protein is unique, maps on chromosome XVI
(13), and shows no similarity to any sequences in the
EMBL/GenBank data bank (S. cerevisiae, Caenorhabditis
elegans, and current versions of Arabidopsis thaliana,
Homo sapiens, and Schizosaccharomyces pombe
genomic sequences). The gene, previously designated YPL007C, was named
TFC8.
To investigate whether TFC8 is essential for growth, one
chromosomal copy of the TFC8 gene was deleted in the diploid
strain YNN281×YNN282 by replacing the ORF by the yeast HIS3
selectable marker. Sporulation and tetrad analysis revealed two viable
His
spores and two nonviable spores, suggesting that
TFC8 was an essential gene. To confirm this conclusion, the
diploid His+ strain (which contains one copy of the
TFC8 gene) was transformed with a 2µ plasmid, pCC12,
harboring the TFC8 gene, and sporulated. Only the resulting
His+ haploid strains containing the pCC12 plasmid with the
TFC8 gene were able to grow. These results demonstrated
that, like all of the previously characterized genes encoding the other
TFIIIC subunits (1, 36, 40, 42, 48, 59), TFC8 is
required for cell viability.
To demonstrate the presence of the TFC8 gene product in
TFIIIC factor, the sequence encoding the HA epitope was fused to the 5'
or to the 3' end of TFC8. A haploid strain which lacked the chromosomal TFC8 gene but expressed the HA C-terminally
tagged
60 (Ctag-
60) grew normally. When the sequence encoding the
HA epitope was fused just after the initiation codon, the growth of the
haploid strain expressing the N-terminally tagged
60 (Ntag-
60) was slightly affected at 30°C (the mutant cells having a doubling time of 130 min in liquid medium, instead of 110 min for the wild-type strain). Furthermore, the Ntag-
60 strain was temperature sensitive. At 37°C, the cells grew with an apparent doubling time of 190 min for
approximately 16 to 18 h before cell death occurred.
TFIIIC factor was purified from these strains, as well as from a strain
expressing an HA-tagged version of
138 (36). Preformed TFIIIC-tDNA3Glu complexes were incubated for 30 min at 25°C with increasing concentrations of anti-HA monoclonal
antibody and analyzed by gel retardation experiments (Fig.
1A). The anti-HA antibody clearly altered
the migration rate of the Ctag-
60
TFIIIC-tDNA3Glu complexes (compare lanes 6 and
7) to the same extent as HA-
138-containing complexes (lanes 11 and
12). On the other hand, the migration rate of Ntag-
60
TFIIIC-tDNA3Glu complexes was not altered
(lanes 9 and 10), even in the presence of 1 µg or more of anti-HA
antibody (data not shown), as if the HA epitope was buried and
inaccessible to the antibody. Note also that, in contrast to previous
results with TFIIIC containing HA-tagged
131 (42) or
138 subunits (see lanes 11 and 12 or reference 36), the binding of the anti-HA antibody to the
Ctag-
60 subunit appeared to cause some dissociation of the
TFIIIC-tDNA3Glu complexes.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 1.
TFC8 encodes the 60-kDa subunit of yeast
TFIIIC. (A) TFIIIC was purified from haploid strains expressing
HA-tagged versions of TFC3 (HA- 138) or TFC8
(Ctag- 60 or Ntag- 60, tagged at the C-terminal or N-terminal end
of Tfc8p, respectively). TFIIIC was preincubated with a
32P-labeled DNA fragment containing the
tRNA3Glu gene for 10 min at 25°C and then
further incubated with various amounts of 12CA5 monoclonal antibody
directed to the HA epitope for 30 min at 25°C. Protein-tDNA complexes
were analyzed by gel retardation assay and revealed by autoradiography.
Lanes 1 and 8, no TFIIIC, no antibody; lanes 2, 7, 9, or 11, no
antibody; lanes 3 to 6, 10, and 12, addition of 12CA5 monoclonal
antibody, as indicated. (B) B, the protease-resistant domain of
TFIIIC, HA-tagged on 138 or 60, was obtained after digestion of
the TFIIIC-tDNA complex with 10 ng of -chymotrypsin for 10 min at
25°C. Digestion was stopped with 1 ng of aprotinin before addition of
the 12CA5 antibody. Left panel, C-terminally HA-tagged TFC8
gene (Ctag- 60); right panel, HA-tagged TFC3 gene
(HA- 138) or N-terminally HA-tagged TFC8 gene
(Ntag- 60). Lanes 1 and 9, control TFIIIC-tDNA complex; lanes 2, 7, and 10, B generated by proteolysis; lanes 3 to 6, 8, and 11, incubation of B-tDNA complex with various amounts of 12CA5
monoclonal antibody, as indicated. , TFIIIC-tDNA complex; -IgG,
immunoglobulin G (IgG)-TFIIIC-tDNA ternary complex; B, B-tDNA
complex; B-IgG, IgG- B-tDNA ternary complex.
|
|
To gain some insight into the localization of
60 within TFIIIC, we
performed a limited proteolysis of TFIIIC-tDNA complexes by
-chymotrypsin. Limited proteolysis of yeast TFIIIC causes the
separation of the transcription factor into two domains of ca. 300 kDa
each, called
A and
B (44). The
B domain generated by proteolysis forms a stable complex with the B block that can be
visualized in gel shift assays and supershifted by the addition of
anti-
138 polyclonal antibodies (19). A similar result was obtained in the present study as anti-HA antibodies neatly supershifted tagged-
138
B-tDNA complexes (Fig. 1B, lanes 7 and 8). When
B-tDNA complexes obtained after limited proteolysis of Ctag-
60
TFIIIC-tDNA complexes were incubated with increasing amounts of anti-HA
antibodies, no defined supershifted band of complex was observed, but
the antibodies reduced the migration rate of
B-tDNA complexes,
causing a marked trailing of the band (Fig. 1B, lanes 2 to 6). A weak accessibility or a partial proteolytic degradation of the HA epitope possibly caused some dissociation of the immune complex during electrophoresis. Such a phenomenon was not observed with Ntag-
60
B-tDNA complexes (lanes 10 and 11), nor with untagged
B-tDNA complexes (data not shown), whose yield and migration rate were unaffected by the monoclonal antibody. Altogether, these gel shift experiments indicated that the polypeptide encoded by TFC8
is part of TFIIIC and that at least its C-terminal end is located in
the
B domain.
In vivo characterization of the Ntag-
60 mutant.
We took
advantage of the thermosensitive phenotype of the Ntag-
60 mutant to
explore the role of the TFC8 gene product in TFIIIC. The
effect of the mutation on Pol III transcripts in vivo is shown in Fig.
2A. The wild-type and mutant cells were
grown at 30°C and then shifted or not to nonpermissive temperature
(37°C) for 6 or 12 h. The cells grown at 30 or 37°C were
incubated at the same temperature with tritiated uracil for 15 min; the
RNAs were then extracted, separated on a 7 M urea gel, and analyzed by
autoradiography. No difference was observed in the RNA labeling pattern
of the wild-type and mutant cells grown at 30°C (lanes 1 and 2). In
contrast, when shifted for 6 or 12 h at 37°C, the mutation
altered the labeling pattern of tRNAs. A smear of radioactivity was
detected just above the labeled tRNA bands (lanes 4 and 5), which could
correspond to partially matured tRNAs, and after 12 h the labeling
of the tRNA bands was selectively reduced (lane 5). Clearly, the fusion
of the HA epitope to
60 at the N-terminal extremity disturbed the
Pol III transcription system. Like in previous studies on different Pol
III system mutants, the synthesis of 5S RNA did not decrease
significantly (20, 41).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 2.
Comparison of in vivo tRNA synthesis in wild-type and
mutant (Ntag- 60) yeast strains. (A) Autoradiogram of the in vivo
pulse-labeling experiments. [3H]uracil incorporation into
wild-type and mutant strains was done for 15 min at 30°C (lane 1, wild-type; lane 2, mutant) or at 37°C after 6 h (lane 4, mutant)
or 12 h (lane 3, wild-type; lane 5, mutant) of growth at 37°C.
RNA species were analyzed by electrophoresis on a 7 M urea gel (6%
polyacrylamide) by using equal amounts of RNA (6 µg per lane). The
asterisk indicates the trailing of radioactive material above the tRNA
species, suggesting a defect in tRNA maturation. (B) Northern blot
analysis of tRNA precursors from wild-type and mutant cells with a
labeled tDNA3Leu probe. RNA extraction was done
after 8 h of growth at 37°C. Gel electrophoresis,
electrophoretic transfer on nylon membrane, and hybridization with DNA
probe was done as described in Materials and Methods. The positions of
the primary transcript of tRNA3Leu, the 5'- and
3'-processed but nonspliced precursor, the spliced but 5'- and
3'-unprocessed precursor, and the mature
tRNA3Leu are indicated on the right. Lanes 1 and 2, wild-type and mutant cells, respectively, containing the
high-copy-number plasmid pFL44L; lane 3, mutant cells containing the
high-copy-number plasmid pFL44L harboring RPR1 gene; lane 4, mutant cells containing pFL44L harboring SPT15 gene (TBP).
|
|
A similar tRNA maturation defect had previously been observed with
thermosensitive mutants of other TFIIIC subunits, such as
138
(37),
131 (56) or, more recently,
91
(1a). To explore a possible relationship between this
maturation defect, TFIIIC function and the cell lethality phenotype, we
performed a Northern blot analysis of various tRNA precursors. Total
RNA was extracted from wild-type and mutant strains grown for 8 h at 37°C, separated by electrophoresis under denaturing conditions, transferred onto a membrane, and probed with various labeled tRNA genes
(Fig. 2B). The wild-type and one mutant strain contained the multicopy
plasmid pFL44L, whereas two other mutant strains contained pFL44L
harboring either RPR1 or SPT15 (TBP). The
precursor pattern of tRNA3Leu in the mutant was
characterized by the presence of an extra RNA band absent in the
wild-type extract (compare lanes 1 and 2). A similar result was
obtained with labeled-SUP4tDNATyr and
tDNA3Glu (data not shown). This additional RNA
species has been previously observed in RNase P mutants and was shown
to correspond to unmatured spliced tRNA (18, 35, 58). RNase
P is an endonuclease that cleaves pre-tRNA substrates to yield a mature
5' extremity. When the RNA component of RNaseP, RPR1, was overexpressed
in the mutant strain, this anomalous RNA species disappeared (lane 3).
However, the mutant cells overexpressing RPR1 retained the
thermosensitive lethal phenotype (see Fig. 3). In contrast to RPR1,
overexpression of TBP did not change the tRNA maturation pattern of the
mutant (Fig. 2, lane 4) but suppressed the lethality (see below). A
direct relationship between the maturation defect and the
thermosensitive phenotype of the Ntag-
60 mutant could therefore be
excluded. The tRNA maturation problem was likely a consequence of the
reduced synthesis of the class III RPR1 RNA, along with other class III transcripts (34).
We looked for multicopy suppressors that could compensate for
interaction defects within TFIIIC or the preinitiation complex. The
Ntag-
60 mutant cells were transformed with high-copy-number plasmids
harboring different genes of the Pol III transcription system. A series
of cell dilutions was plated on minimal medium and incubated at
permissive or nonpermissive temperature. Among the TFIIIC genes,
besides TFC8, only TFC1 (encoding
95) acted as
a multicopy suppressor (Fig. 3 and Table
1). None of the suppressors of
tsv115 mutation in TFC3, such as RPR1,
NOP1, and FHL1 (37), involved in the
maturation of stable RNAs, were able to suppress the thermosensitive
defect of the mutant cells (Table 1). Figure 3 shows that high dosage
of two TFIIIB genes, TFC5 (TFIIIB90), and SPT15
(TBP), but not BRF1 (TFIIIB70), suppressed the lethal phenotype of Ntag-
60 mutant cells on minimal medium at 37°C. Remarkably, only the overproduction of SPT15 (TBP) could
restore cell growth on a rich YPD medium at the nonpermissive
temperature (the suppression level was weaker under these conditions
than the one observed on minimal medium, see Table 1).

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 3.
Suppressibility of Ntag- 60 mutation by overexpression
of Pol III-related genes. Stationary-phase cultures of mutant cells
harboring different multicopy plasmids were diluted 10-, 102-, and 103-fold in water and spotted (5 µl) onto solid minimum medium (Casa+Ade plates). The plates were
incubated for 4 days at 37°C. The different genes harbored on the
high-copy-number vector pFL44L are indicated. , plasmid without
insert. RPR1 encodes the RNA cofactor of RNase P.
|
|
In vitro characterization of the Ntag-
60 mutant.
TFIIIC
factor was partially purified from a wild-type strain and from the
strain expressing the HA N-terminal version of
60 to compare their
DNA binding properties. TFIIIC fractions purified from the mutant
strain were reproducibly found by Western blotting with anti-
60 and
anti-
55 polyclonal antibodies (40) to contain half as
much TFIIIC as wild-type fractions. Therefore, care was taken to use
the same amount of wild-type or mutant TFIIIC in the following gel
retardation experiments. Two labeled probes, tDNA3Glu or SUP4tDNATyr,
were incubated with limiting amounts of wild-type or mutant TFIIIC.
TFIIIC-tDNA complexes were analyzed by electrophoresis under
nondenaturing conditions and revealed by autoradiography. Figure
4A shows that the yields of TFIIIC-DNA
complexes formed with wild-type or mutant TFIIIC factor on
tDNA3Glu or SUP4tDNATyr
were very similar. In addition, wild-type and mutant TFIIIC-tDNA complex stabilities at various temperatures or ionic strengths were
also indistinguishable (data not shown). In contrast, when TFIIIC-tDNA3Glu complexes were subjected to
limited proteolysis, significantly fewer mutant
B-tDNA complexes
were obtained compared to the wild type (Fig. 4B, compare lanes 2 and
9). Moreover, mutant
B-tDNA complexes were less stable than wild
type at increasing temperatures. The amount of mutant
B-tDNA
complexes decreased drastically after 10 min at 55°C to 5% of the
initial control level at 25°C, while 60% of wild-type
B-tDNA
complexes resisted under the same conditions (lanes 6 and 13), as
determined by using a PhosphorImager with ImageQuant software
(Molecular Dynamics). Whatever the structural defect causing the
increased thermolability (either the presence of the HA epitope or some
subtle difference in proteolysis indirectly caused by the presence of
the epitope), these observations clearly revealed a defect at the
B
level, enforcing the idea that the N-terminal part of
60 belongs to
the B block-binding domain.

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 4.
DNA-binding properties of wild-type and mutant TFIIIC.
(A) TFIIIC-tDNA complex formation on tRNA3Glu
or SUP4tRNATyr genes. TFIIIC-DNA complexes were
formed with Ntag- 60 or wild-type TFIIIC preparations (MonoQ
fraction) and analyzed by electrophoresis as described in Materials and
Methods. To add similar amounts of wild-type and mutant TFIIIC (based
on Western blot experiments), twice as much mutant protein fraction was
added as follows: 25 ng (lanes 2 and 7) and 100 ng (lanes 3 and 8) of
wild-type TFIIIC and 50 ng (lanes 4 and 9) and 200 ng (lanes 5 and 10)
of mutant TFIIIC fraction. Lanes 1 to 5, tRNA3Glu gene; lanes 6 to 10, SUP4tRNATyr gene. (B) Effect of temperature on
B-tDNA complex stability. Preformed
TFIIIC-tDNA3Glu complexes were digested with
-chymotrypsin to generate B-DNA complexes, proteolytic digestion
was stopped by addition of aprotinin, and the mixtures were then
further incubated for 10 min at various temperatures as indicated.
Lanes 1 and 8, wild-type and mutant TFIIIC-tDNA complexes,
respectively; lanes 2 to 7, wild-type B; lanes 9 to 14, mutant B.
, TFIIIC-tDNA complex; B, B-tDNA complex.
|
|
Wild-type and mutant TFIIIC were then compared for their ability to
direct specific transcription of various tRNA genes in vitro. Identical
amounts of both TFIIIC preparations, calibrated by Western blot
analysis with anti-
60 and anti-
55 polyclonal antibodies and by
gel retardation analysis with tDNA3Glu or
SUP4tDNATyr probes, were used in reconstituted
transcription assays in the presence of B" fraction, recombinant TBP
(rTBP), TFIIIB70 (rTFIIIB70), and purified RNA Pol III. As shown in
Fig. 5, the transcriptional activity of
mutant TFIIIC was similar to that of the wild-type factor with
tDNA3Glu, tDNA2Lys, or
tDNA1Ile as templates (lanes 1 and 2, 7 and 8, and 11 and 12). Surprisingly, the transcriptional activity of the
mutant factor was much impaired with other templates, such as
SUP4tDNATyr, tDNA1Phe,
or tDNA1Pro (lanes 3 to 6 and 9 and 10).
However, as shown previously, the mutant and wild-type factor
preparations bound similarly to tDNA3Glu or
SUP4tDNATyr probes (see above). Since a
difference in DNA-binding properties could not account for such a
difference in transcription efficiency, we explored the ability of
mutant TFIIIC to recruit TFIIIB. We used
tDNA3Leu, which was, like
SUP4tDNATyr, a poor template, with the mutant
TFIIIC. Wild-type or mutant TFIIIC had also similar DNA-binding
properties on tDNA3Leu (data not shown).
Transcription was performed in the presence of increasing amounts of
TFIIIB with the same amount of wild-type or mutant TFIIIC. Remarkably,
as shown in Fig. 6A, high doses of TFIIIB
fraction could compensate for the transcription defect of mutant
TFIIIC. The relative transcriptional activity of mutant TFIIIC reached
92% of the wild-type level at 19 ng of TFIIIB per µl, a
concentration at which TFIIIB was no longer limiting with wild-type
TFIIIC (the maximum of tRNA synthesis in the presence of wild-type
TFIIIC was reached at ca. 15 ng of TFIIIB per µl).

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 5.
Specific transcription of various tRNA genes in the
presence of wild-type or mutant TFIIIC. In vitro transcription was
performed as described in Materials and Methods by using 100 and 200 ng
of wild-type and Ntag- 60 MonoQ-TFIIIC fraction (respectively), rTBP,
rTFIIIB70, partially purified B" fraction, and RNA Pol III. The
different plasmid templates are indicated. Odd lanes, wild-type TFIIIC.
Even lanes, mutant TFIIIC.
|
|

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 6.
Effects of TFIIIB, TFIIIB70, B", or TBP concentration on
the transcription of tRNA3Leu or
tRNA3Glu genes in the presence of wild-type or
mutant TFIIIC. (A) Effect of TFIIIB. Transcription mixtures (40 µl)
contained 100 ng of wild-type or 200 ng of Ntag- 60 TFIIIC, 220 ng of
plasmid DNA harboring the tRNA3Leu gene, RNA
polymerase, and various concentrations of TFIIIB (Cibacron blue
fraction) as indicated. (B) Effect of TFIIIB70. Transcription mixtures
contained wild-type or mutant TFIIIC, plasmid DNA, and RNA polymerase
as in panel A, 2.5 ng of rTBP per µl, 45 ng of partially purified B"
fraction per µl, and various concentrations of rTFIIIB70 as
indicated. (C) Effect of B". Transcription mixtures contained wild-type
or mutant TFIIIC, plasmid DNA, and RNA polymerase as in panel A, 4 ng
of rTBP per µl, 35 ng of rTFIIIB70 per µl, and various
concentrations of partially purified B" fraction as indicated. (D)
Effect of TBP. Lanes were as in other panels, with 35 ng of rTFIIIB70
per µl, 45 ng of partially purified B" fraction per µl, and various
concentrations of rTBP as indicated. (E) Effect of TBP. Lanes are as
described for panel D, except that plasmid DNA harboring the
tRNA3Glu gene instead of the
tRNA3Leu gene was used as the template.
Transcripts were analyzed by electrophoresis and autoradiography (left
panels). Odd lanes, wild-type TFIIIC; even lanes, mutant TFIIIC.
Transcripts were quantified (right panels) by using a PhosphorImager
and ImageQuant software (Molecular Dynamics). a.u., arbitrary units.
Gray bars, wild-type TFIIIC; black bars, mutant TFIIIC. The relative
transcription efficiencies of the mutant versus the wild-type TFIIIC
are indicated above the bar graphs. ND, not determined. Two or three
independent experiments were compiled for quantification.
|
|
To explore which TFIIIB component was critical for TFIIIB assembly by
mutant TFIIIC, we performed multiple-round transcriptions with
tDNA3Leu as template with various amounts of
rTFIIIB70 (Fig. 6B), B" (Fig. 6C), or rTBP (Fig. 6D). Increasing the
concentration of rTFIIIB70 did not correct the transcription defect of
mutant TFIIIC (Fig. 6B). In a 12- to 48-ng/µl concentration range of
rTFIIIB70 factor, tRNA synthesis increased similarly for both wild-type
and mutant TFIIIC, and the relative transcriptional efficiency of
mutant TFIIIC remained low and constant (8 to 16%). At a concentration of more than 48 ng/µl, rTFIIIB70 appeared to titrate a component of
the transcription system, causing a dramatic decrease of tRNA synthesis
directed by both wild-type and mutant TFIIIC. As shown in Fig. 6C,
increasing the concentration of B" in a 11- to 45-ng/µl concentration
range also did not correct the transcription of B" in a 11- to
45-ng/µl concentration range also did not correct the transcription
defect of mutant TFIIIC. At a concentration of B" of >45 ng/µl, the
transcription efficiency of both wild-type and mutant TFIIIC decreased
similarly (Fig. 6C). The dosage-dependent effect of rTBP on
transcriptional efficiency was totally different (Fig. 6D). In a
concentration range of 2.5 to 8 ng of rTBP factor per µl, the
transcriptional efficiency was optimal for wild-type TFIIIC. In
contrast, with mutant TFIIIC, the tRNA synthesis rate increased with
rTBP concentration to reach 97% of the wild-type level. This result
indicated that rTBP was the limiting component for TFIIIB assembly
directed by mutant TFIIIC, at least on
tDNA3Leu.
The observation that several tRNA genes were normally transcribed in
the presence of mutant TFIIIC (Fig. 5) suggested that these templates
might have different TBP requirements. Indeed, we found that decreasing
the TBP concentration revealed a defect of mutant TFIIIC in the
transcription of tDNA3Glu template (Fig. 6E).
Therefore, we inferred that the TBP concentration of our standard
transcription assay was optimal for tDNA3Glu,
tDNA2Lys, and tDNA1Ile
but limiting with SUP4tDNATyr,
tDNA1Phe, tDNA1Pro, and
tDNA3Leu. The analysis of the promoter region
of these genes did not disclose a feature within the TFIIIB binding
region that might account for such a differential TBP requirement.
60 interacts with TBP.
Two lines of evidence indicated that
mutant TFIIIC was defective in TBP recruitment, both in vivo (the
multicopy suppressor studies) and in vitro (the transcription
experiments). We therefore explored the possibility that
60 subunit
might directly participate in TBP binding. The physical interaction
between
60 and TBP was investigated by coimmunoprecipitation
experiments with recombinant proteins. rTBP (200 ng) was preincubated
for 90 min at 25°C with HA-r
60 (650 ng) in transcription buffer.
The protein samples were then added to magnetic beads precoated with
anti-HA antibodies, the beads were washed with the same buffer, and
bound proteins were eluted with SDS or by competition with the HA
peptide. The input and eluted proteins were subsequently analyzed by
SDS-PAGE and immunoblotting with anti-TBP and anti-
60 antibodies
(Fig. 7). Compared to the low background
level of TBP retained by the beads in the absence of
60, a
sevenfold-higher amount of TBP was bound upon preincubation with
60,
as quantified by using the ImageQuant software. A similar result was
obtained when bound proteins were eluted by competition with the HA
peptide or when the beads were washed extensively with the
transcription buffer (data not shown). The background-corrected
TBP/Tfc8 ratio in the eluted fraction has been quantified and
corresponded to 0.56 (compared to 0.9 in the input), showing that each
molecule of bound
60 was specifically associated to 0.5 molecule of
TBP. From that result, we tentatively estimate the
Kd of TBP-
60 interaction to be ca. 100 nM,
which is indicative of a reasonably strong interaction. The same
Kd was reported for TFIIIB70-TBP interaction by
Sethy-Coraci et al. (55). These observations strongly
suggested a direct interaction between the
60 subunit and TBP. In a
similar experiment, no physical interaction could be detected between
r
60 and rTFIIIB70: Western blot analysis revealed no significant
difference in the amounts of rTFIIIB70 bound to the beads in the
presence or absence of HA-r
60 (data not shown).

View larger version (90K):
[in this window]
[in a new window]
|
FIG. 7.
Coimmunoprecipitation experiment. HA-tagged r 60 (650 ng) was preincubated with rTBP (200 ng) for 1.5 h at 25°C and
purified on magnetic beads coated with anti-HA antibodies. Bound
proteins were eluted and analyzed by Western blotting with anti- 60
and anti-TBP polyclonal antibodies. The positions of rTBP and of native
HA-r 60 are shown. The intermediate bands are specifically revealed
by anti- 60 antibodies. Lane 1, rTBP+HA-r 60; lane 2, rTBP alone;
lane 3, 25% of input rTBP+HA-r 60 proteins.
|
|
 |
DISCUSSION |
We report here the characterization of the 60-kDa
polypeptide present in affinity-purified TFIIIC. This polypeptide,
named
60, is shown to be an essential subunit of TFIIIC. The yeast TFIIIC factor, therefore, comprises six subunits,
138,
131,
95,
91,
60, and
55, all of which are essential for cell
viability (Table 2).
60 appears to
reside, at least in part, in
B, the downstream DNA-binding domain.
Paradoxically, however, analysis of a
60 mutant indicated that
60
plays a role in TFIIIB assembly via its interaction with TBP. The
results suggest a network of interactions linking TFIIIC to TFIIIB
components during preinitiation complex formation.
The demonstration that
60 is an integral subunit of TFIIIC rests on
biochemical and genetic evidence. First, antibodies directed to
C-terminally HA-tagged
60 altered the migration of tagged TFIIIC-tDNA and
B-tDNA complexes. Second, a thermosensitive mutant TFIIIC (harboring N-terminally HA-tagged
60) was affected in tRNA
gene transcription in vivo and in vitro. Third, this in vivo phenotype
was suppressed by overexpression of components of the class III
transcription machinery (a TFIIIC subunit,
95, and two components of
the TFIIIB factor, TFIIIB90/B" and TBP). Fourth, the in vitro
transcription defect was strongly alleviated by increasing the
concentration of TFIIIB or TBP. Finally, like all of the subunits of
TFIIIC previously characterized, the TFC8 gene encoding
60 is essential for cell viability. Altogether, these results
indicate that
60 plays an important role in TFIIIC.
The location of TFIIIC subunits by site-specific DNA cross-linking has
provided a broad view of the possible functions of the different
polypeptides within the TFIIIC-DNA complex (Table 2), which are always
in good agreement with other biochemical or genetic data
(28). Unfortunately,
60 was the only TFIIIC polypeptide
that could not be cross-linked and located by this elegant and powerful
approach (its subunit status could have been questioned for that
reason). Two independent experiments suggested that
60 resides
within
B domain:
B-DNA complexes obtained by proteolysis of
TFIIIC harboring HA-tagged
60 were found to be more thermosensitive
than untagged complexes or were recognized by antibodies directed to
the HA epitope. Since, in these experiments, the HA tag was placed
either at the N-terminal or at the C-terminal end of the polypeptide,
we inferred that both extremities of
60 resided in
B, together
with
138 (19) and
91 (1). The total mass of
these three polypeptides, 275 kDa, would correspond reasonably well to
the mass of
B (~300 kDa) visualized by scanning transmission electron microscopy over the B block (53). Note that the
definition of
B by electron microscopy and by limited proteolysis
are not necessarily equivalent. The protease-resistant form of
B
observed by gel retardation assay may contain pieces of TFIIIC
unrelated to the B-block-binding function. The participation of
60
to
B (as defined by limited proteolysis and gel retardation assay) points to a role of this subunit in DNA binding. Indeed, the presence of the HA epitope at the N-terminal end of
60 decreased the yield and weakened the stability of
B-DNA complex. However, mutant TFIIIC-DNA complex formation was not notably affected compared to the
wild-type factor, even under unfavorable conditions, at high ionic
strengths, or at high temperatures. Therefore, a role of
60 in DNA
binding is not excluded but is not strongly supported by the present
data, in keeping with the lack of detectable
60-DNA cross-linking
(28). Schematic models of TFIIIC-DNA complexes based on
site-specific cross-linking studies tentatively visualized the 60-kDa
polypeptide as being unbound to DNA, connecting the
95 and
138
subunits, and overlapping the A block-B block interval (10).
This proposal fits remarkably well with our present observations, since
60 appears to reside at least partly in
B and possibly also
contact
95, as suggested by the in vivo suppression of
60 mutant
lethality by overexpression of
95, although two-hybrid experiments
did not confirm this interaction (data not shown).
In view of the position of
60 in the TFIIIC-DNA complex, the effect
of a
60 mutation at the level of TFIIIB recruitment was rather
unexpected. Since
131 was the only subunit of TFIIIC extending
upstream of the transcriptional start site (7), it has been
assumed to be entirely responsible for TFIIIB assembly. Indeed,
131
and no other TFIIIC subunit was found to interact with TFIIIB70/Brf1
and TFIIIB90/B" (14, 33, 51). Several lines of evidence,
however, indicate that
60 most likely also participates in TFIIIB
recruitment: (i) the lethality of the Ntag-
60 variant at a
nonpermissive temperature was suppressed by overexpression of two
TFIIIB components, TFIIIB90/B" and TBP (not by TFIIIB70 though); (ii)
the in vitro transcription defect of the mutant TFIIIC was strongly
alleviated by increasing TFIIIB concentration and more specifically by
increasing TBP concentration (again not TFIIIB70 or B"); and (iii)
60 was found to interact directly with TBP. The possibility of an
indirect role of
60 in TFIIIB recruitment could be envisioned in
view of its possible interaction with
95 that belongs to the
A
domain. The
60 mutation could perturb
95-A block binding or
affect indirectly, via
95, TFIIIB assembly by
131. If this were
the case, one would expect a suppression of the in vivo or in vitro
defects by increased TFIIIB70 dosage. Indeed, mutations in TFIIIC
(37), in TBP (12, 16), or in promoter elements
decreasing factor-DNA interaction (39) were always found to
be best suppressed in vivo by overexpression of TFIIIB70. This makes
sense since TFIIIB70 interacts with TFIIIC (14, 33),
initiates TFIIIB assembly (31), and appears to be limiting
for transcription both in whole-cell extracts and in vivo (39, 54,
55). Since increasing the TFIIIB70 concentration did not correct
the TFIIIC mutant phenotype in vivo and in vitro, the rate-limiting
step caused by the
60 mutation was expected to follow TFIIIB70
recruitment step, i.e., the TBP recruitment step (31). Since
it appears unlikely that the
60 mutation would have an indirect
effect on the recruitment of TBP by TFIIIB70, we rather favor the idea
that
60 is directly involved in TFIIIB recruitment by contacting
TBP. The coimmunoprecipitation of TBP and
60 comes in support of
this proposal. The interaction of TBP with TFIIIC subunits has not been
previously reported. However, Huet et al. (26) have noted
that TBP slightly retarded the migration of TFIIIC-DNA complexes on a
TATA-less gene. Since TFIIIC specifies the orientation of TFIIIB on the
DNA (and thereby the direction of transcription) (60), the
direct interaction of TFIIIC with TBP, via
60, might well contribute
to fix its correct orientation on the DNA. Alternatively,
60-TBP
interaction may not be involved in positioning TBP on the DNA but only
represent a transient step facilitating the delivery of TBP to the
TFIIIB70-TFIIIC-DNA complex.
We are grateful to Christophe Carles, Michel Riva, Olivier
Lefebvre, and Françoise Bouet for their help in peptide
microsequence determination and to Jacques Grassi and Christophe
Creminon for their help in raising polyclonal antibodies. We thank
Emmanuel Favry for protein preparations and Olivier Lefebvre for advice on TFIIIC purification and immunoprecipitation experiments. We also
thank Christian Marck and Hélène Dumay for providing
plasmids harboring different tRNA genes and for helpful discussions and Olivier Lefebvre, Michel Riva, and Michel Werner for improving the manuscript.
E.D. was supported by postdoctoral fellowships from the Association
pour la Recherche contre le Cancer, the Ligue Nationale contre le
Cancer, and the Fondation pour la Recherche Médicale, and R.A.
was supported by a postdoctoral fellowship from the European Union
(Marie Curie Training and Mobility of Researchers).
| 1.
|
Arrebola, R.,
N. Manaud,
S. Rozenfeld,
M. C. Marsolier,
O. Lefebvre,
C. Carles,
P. Thuriaux,
C. Conesa, and A. Sentenac.
1998.
91, an essential subunit of yeast TFIIIC, cooperates with 138 in DNA binding.
Mol. Cell. Biol.
18:1-9[Abstract/Free Full Text].
|
| 1a.
| Arrebola, R. Unpublished data.
|
| 2.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl.
1994.
Current protocols in molecular biology.
John Wiley & Sons, Inc., New York, N.Y
|
| 3.
|
Baker, R. E.,
S. Camier,
A. Sentenac, and B. D. Hall.
1987.
Gene size differentially affects the binding of yeast transcription factor to two intragenic regions.
Proc. Natl. Acad. Sci. USA
84:8768-8772[Abstract/Free Full Text].
|
| 4.
|
Baker, R. E.,
O. S. Gabrielsen, and B. D. Hall.
1986.
Effects of tRNATyr point mutations on the binding of yeast RNA polymerase III transcription factor C.
J. Biol. Chem.
261:5275-5282[Abstract/Free Full Text].
|
| 5.
|
Bartholomew, B.,
B. R. Braun,
G. A. Kassavetis, and E. P. Geiduschek.
1994.
Probing close DNA contacts of RNA polymerase III transcription complexes with the photoactive nucleoside 4-thiodeoxythymidine.
J. Biol. Chem.
269:18090-18095[Abstract/Free Full Text].
|
| 6.
|
Bartholomew, B.,
G. A. Kassavetis,
B. R. Braun, and E. P. Geiduschek.
1990.
The subunit structure of Saccharomyces cerevisiae transcription factor IIIC probed with a novel photocrosslinking reagent.
EMBO J.
9:2197-2205[Medline].
|
| 7.
|
Bartholomew, B.,
G. A. Kassavetis, and E. P. Geiduschek.
1991.
Two components of Saccharomyces cerevisiae transcription factor IIIB (TFIIIB) are stereospecifically located upstream of a tRNA gene and interact with the second-largest subunit of TFIIIC.
Mol. Cell. Biol.
11:5181-5189[Abstract/Free Full Text].
|
| 8.
|
Baudin, A.,
O. Ozier-Kalogeropoulos,
A. Denouel,
F. Lacroute, and C. Cullin.
1993.
A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae.
Nucleic Acids Res.
21:3329-3330[Free Full Text].
|
| 9.
|
Bonneaud, N.,
O. Ozier-Kalogeropoulos,
G. Li,
M. Labouesse,
L. Minvielle-Sebastia, and F. Lacroute.
1991.
A family of low and high copy replicative, integrative and single-stranded S. cerevisiae/E. coli shuttle vectors.
Yeast
7:609-615[Medline].
|
| 10.
|
Braun, B. R.,
B. Bartholomew,
G. A. Kassavetis, and E. P. Geiduschek.
1992.
Topography of transcription factor complexes on the Saccharomyces cerevisiae 5 S RNA gene.
J. Mol. Biol.
228:1063-1077[Medline].
|
| 11.
|
Braun, B. R.,
G. A. Kassavetis, and E. P. Geiduschek.
1992.
Bending of the Saccharomyces cerevisiae 5S rRNA gene in transcription factor complexes.
J. Biol. Chem.
267:22562-22569[Abstract/Free Full Text].
|
| 12.
|
Buratowski, S., and H. Zhou.
1992.
A suppressor of TBP mutations encodes an RNA polymerase III transcription factor with homology to TFIIB.
Cell
71:221-230[Medline].
|
| 13.
|
Bussey, H.,
R. K. Storms,
A. Ahmed,
K. Albermann,
E. Allen,
W. Ansorge,
R. Araujo,
A. Aparicio,
B. Barrell,
K. Badcock,
V. Benes,
D. Botstein,
S. Bowman,
M. Bruckner,
J. Carpenter,
J. M. Cherry,
E. Chung,
C. Churcher,
F. Coster,
K. Davis,
R. W. Davis,
F. S. Dietrich,
H. Delius,
T. DiPaolo,
J. Hani, et al.
1997.
The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI.
Nature
387:103-105[Medline].
|
| 14.
|
Chaussivert, N.,
C. Conesa,
S. Shaaban, and A. Sentenac.
1995.
Complex interactions between yeast TFIIIB and TFIIIC.
J. Biol. Chem.
270:15353-15358[Abstract/Free Full Text].
|
| 15.
|
Church, G. M., and W. Gilbert.
1984.
Genomic sequencing.
Proc. Natl. Acad. Sci. USA
81:1991-1995[Abstract/Free Full Text].
|
| 16.
|
Colbert, T., and S. Hahn.
1992.
A yeast TFIIB-related factor involved in RNA polymerase III transcription.
Genes Dev.
6:1940-1949[Abstract/Free Full Text].
|
| 17.
|
Conesa, C.,
R. N. Swanson,
P. Schultz,
P. Oudet, and A. Sentenac.
1993.
On the subunit composition, stoichiometry, and phosphorylation of the yeast transcription factor TFIIIC/ .
J. Biol. Chem.
268:18047-18052[Abstract/Free Full Text].
|
| 18.
|
Dichtl, B., and D. Tollervey.
1997.
Pop3p is essential for the activity of the RNase MRP and RNase P ribonucleoproteins in vivo.
EMBO J.
16:417-429[Medline].
|
| 19.
|
Gabrielsen, O. S.,
N. Marzouki,
A. Ruet,
A. Sentenac, and P. Fromageot.
1989.
Two polypeptide chains in yeast transcription factor interact with DNA.
J. Biol. Chem.
264:7505-7511[Abstract/Free Full Text].
|
| 20.
|
Gudenus, R.,
S. Mariotte,
A. Moenne,
A. Ruet,
S. Mémet,
J.-M. Buhler,
A. Sentenac, and P. Thuriaux.
1988.
Conditional mutants of RPC160, the gene encoding the largest subunit of RNA polymerase C in Saccharomyces cerevisiae.
Genetics
119:517-526[Abstract/Free Full Text].
|
| 21.
|
Heinemeyer, W.,
A. Gruhler,
V. Mohrle,
Y. Mahe, and D. H. Wolf.
1993.
PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chymotryptic activity and degradation of ubiquinated proteins.
J. Biol. Chem.
268:5115-5120[Abstract/Free Full Text].
|
| 22.
|
Hermann-Le Denmat, S.,
M. Werner,
A. Sentenac, and P. Thuriaux.
1994.
Suppression of yeast RNA polymerase III mutations by FHL1, a gene coding for a fork head protein involved in rRNA processing.
Mol. Cell. Biol.
14:2905-2913[Abstract/Free Full Text].
|
| 23.
|
Hsieh, Y.-J.,
Z. Wang,
R. Kovelman, and R. G. Roeder.
1999.
Cloning and characterization of two evolutionarily conserved subunits (TFIIIC102 and TFIIIC63) of human TFIIIC and their involvement in functional interactions with TFIIIB and RNA polymerase III.
Mol. Cell. Biol.
19:4944-4952[Abstract/Free Full Text].
|
| 24.
|
Huet, J.,
C. Conesa,
C. Carles, and A. Sentenac.
1997.
A cryptic DNA binding domain at the COOH terminus of TFIIIB70 affects formation, stability, and function of preinitiation complexes.
J. Biol. Chem.
272:18341-18349[Abstract/Free Full Text].
|
| 25.
|
Huet, J.,
N. Manaud,
G. Dieci,
G. Peyroche,
C. Conesa,
O. Lefebvre,
A. Ruet,
M. Riva, and A. Sentenac.
1996.
RNA polymerase III and class III transcription factors from Saccharomyces cerevisiae.
Methods Enzymol.
273:249-267[Medline].
|
| 26.
|
Huet, J., and A. Sentenac.
1992.
The TATA-binding protein participates in TFIIIB assembly on tRNA genes.
Nucleic Acids Res.
20:6451-6454[Abstract/Free Full Text].
|
| 27.
|
Joazeiro, C. A. P.,
G. A. Kassavetis, and E. P. Geiduschek.
1994.
Identical components of yeast transcription factor IIIB are required and sufficient for transcription of TATA box-containing and TATA-less genes.
Mol. Cell. Biol.
14:2798-2808[Abstract/Free Full Text].
|
| 27a.
| Jourdain, S. Personal communication.
|
| 28.
|
Kassavetis, G. A.,
C. Bardeleben,
B. Bartholomew,
B. R. Braun,
C. A. P. Joazeiro,
M. Pisano, and E. P. Geiduschek.
1994.
Transcription by RNA polymerase III, p. 107-126.
In
R. C. Conaway, and J. W. Conaway (ed.), Transcription: mechanisms and regulation. Raven Press, Ltd., New York, N.Y
|
| 29.
|
Kassavetis, G. A.,
B. Bartholomew,
J. A. Blanco,
T. E. Johnson, and E. P. Geiduschek.
1991.
Two essential components of the Saccharomyces cerevisiae transcription factor TFIIIB: transcription and DNA-binding properties.
Proc. Natl. Acad. Sci. USA
88:7308-7312[Abstract/Free Full Text].
|
| 30.
|
Kassavetis, G. A.,
B. R. Braun,
L. H. Nguyen, and E. P. Geiduschek.
1990.
S. cerevisiae TFIIIB is the transcription initiation factor proper of RNA polymerase III, while TFIIIA and TFIIIC are assembly factors.
Cell
60:235-245[Medline].
|
| 31.
|
Kassavetis, G. A.,
C. A. P. Joazeiro,
M. Pisano,
E. P. Geiduschek,
T. Colbert,
S. Hahn, and J. A. Blanco.
1992.
The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB.
Cell
71:1055-1064[Medline].
|
| 32.
|
Kassavetis, G. A.,
S. T. Nguyen,
R. Kobayashi,
A. Kumar,
E. P. Geiduschek, and M. Pisano.
1995.
Cloning, expression, and function of TFC5, the gene encoding the B" component of the Saccharomyces cerevisiae RNA polymerase III transcription factor TFIIIB.
Proc. Natl. Acad. Sci. USA
92:9786-9790[Abstract/Free Full Text].
|
| 33.
|
Khoo, B.,
B. Brophy, and S. P. Jackson.
1994.
Conserved functional domains of the RNA polymerase III general transcription factor BRF.
Genes Dev.
8:2879-2890[Abstract/Free Full Text].
|
| 34.
|
Lee, J. Y.,
C. F. Evans, and D. R. Engelke.
1991.
Expression of RNase P RNA in Saccharomyces cerevisiae is controlled by an unusual RNA polymerase III promoter.
Proc. Natl. Acad. Sci. USA
88:6986-6990[Abstract/Free Full Text].
|
| 35.
|
Lee, J. Y.,
C. E. Rohlman,
L. A. Molony, and D. R. Engelke.
1991.
Characterization of RPR1, an essential gene encoding the RNA component of Saccharomyces cerevisiae nuclear RNase P.
Mol. Cell. Biol.
11:721-730[Abstract/Free Full Text].
|
| 36.
|
Lefebvre, O.,
C. Carles,
C. Conesa,
R. N. Swanson,
F. Bouet,
M. Riva, and A. Sentenac.
1992.
TFC3: Gene encoding the B-block binding subunit of the yeast transcription factor TFIIIC.
Proc. Natl. Acad. Sci. USA
89:10512-10516[Abstract/Free Full Text].
|
| 37.
|
Lefebvre, O.,
J. Rüth, and A. Sentenac.
1994.
A mutation in the largest subunit of yeast TFIIIC affects tRNA and 5 S RNA synthesis. Identification of two classes of suppressors.
J. Biol. Chem.
269:23374-23381[Abstract/Free Full Text].
|
| 38.
|
Léveillard, T.,
G. A. Kassavetis, and E. P. Geiduschek.
1991.
Saccharomyces cerevisiae transcription factors IIIB and IIIC bend the DNA of a tRNAGln gene.
J. Biol. Chem.
266:5162-5168[Abstract/Free Full Text].
|
| 39.
|
López-De-León, A.,
M. Librizzi,
K. Puglia, and I. Willis.
1992.
PCF4 encodes an RNA polymerase III transcription factor with homology to TFIIB.
Cell
71: |